Punctate palmoplantar keratoderma type 1 (TPK 1) is a hereditary disorder characterized by the appearance of small, symmetrically located, horny growths on the palms and soles. These growths are hyperkeratosis and their size, as a rule, does not exceed a few millimeters in diameter. The disease can manifest itself from an early age, leading to limited joint mobility and a decrease in the quality of life, since the symptoms are often accompanied by itching and pain. TPK 1 is part of a group of keratodermas that, depending on the type and severity of manifestation, can vary significantly and have different genetic mechanisms and pathogenesis.
History of the disease and interesting historical facts
Punctate palmoplantar keratoderma was first described in the scientific literature in the 1940s, when scientists began to better understand inherited dermatological diseases. Because TPK 1 is more common in certain ethnic groups, capturing information about this disease in population reference maps became an important area of research. Keratodermas attracted the attention of not only dermatologists but also geneticists, since understanding the mechanisms of pain transmission can be used to advance knowledge about inherited diseases. In the 1960s, the first attempts at genetic mapping of diseases began, which helped to identify the influence of mutations in certain genes on the development of TPK 1.
Epidemiology
The prevalence of punctate palmoplantar keratoderma varies among populations. According to the latest epidemiological data, the incidence varies depending on the geographic area and ethnic origin. Among Europeans, TPK 1 is diagnosed with a frequency of approximately 1 in 30,000 people. For some populations, such as African people and Native American tribes, the incidence may be significantly higher due to a certain genetic predisposition. General statistics show a higher predisposition to the disease among men, which may be associated with certain gene expression factors.
Genetic predisposition to this disease
TPK 1 is an autosomal recessive disorder, meaning that two recessive alleles in genes are required for the disorder to manifest. The main genes involved include KRT17, which encodes the keratin protein responsible for the integrity and protective functions of the epidermis. Mutations in this gene can lead to impaired keratinization, which is the main pathogenetic mechanism of TPK 1. Other associated mutations can also involve genes responsible for lipid extraction, transport, and metabolism, highlighting the complex, multifactorial nature of the disease.
Risk factors for the development of this disease
Risk factors for palmoplantar keratoderma punctata include:
- Genetic predisposition, mainly in families where the disease has become known.
- Physical factors such as trauma or friction to the skin, which can promote keratinization.
- Chemical factors, including prolonged contact with certain chemicals or household products that may irritate the skin.
- Environmental conditions, including high humidity and temperature, post-structural changes in the skin.
It is important to consider that a combination of several factors can significantly increase the risk of developing the disease.
Diagnosis of this disease
Diagnosis of TPK 1 requires a comprehensive assessment of the patient's condition, covering the following aspects:
- The main symptoms include the appearance of small, painful, horny growths, especially on the palms and soles.
- Laboratory tests may include genetic testing to look for mutations in specific genes, such as KRT17.
- Radiological examinations are not usually performed, but may be modulated according to clinical indications to determine the condition of the joints.
- Other diagnostic tests may include skin biopsy followed by histological examination.
- The differential diagnosis includes a number of dermatological conditions such as psoriasis, eczema and other forms of keratoderma.
Treatment
Treatment of punctate palmoplantar keratoderma requires an individual approach and may include:
- General treatment aimed at improving the skin condition through the use of moisturizers and keratolytic agents.
- Pharmacological treatment, including the use of topical corticosteroids to reduce inflammation.
- Surgery may be considered in emergency cases to remove large growths.
- Other treatments include ultraviolet light therapy and the use of pressure bandages on the affected areas.
It should be taken into account that the effectiveness of treatment may vary, and the relevance of each method requires discussion with the patient.
List of medications used to treat this disease
The main medications used to treat palmoplantar keratoderma punctata include:
- Keratolytic agents (eg, salicylic acid).
- Topical corticosteroids (eg, betamethasone).
- Moisturizing and softening creams (eg Vaseline).
- Dermatological preparations for topical use (eg, urethane ointment).
Import substitution of drugs and the search for similar models can also influence the choice of products.
Disease monitoring
Monitoring the patient's condition requires periodic control steps:
- Regular assessment of skin condition and effectiveness of prescribed treatment, ideally every 3-6 months.
- The prognosis for TPK 1 can vary, but most patients manage symptoms with local treatment.
- Complications such as infectious processes and chronic inflammation should be early subjects of monitoring.
Age-related features of the disease
Punctate palmoplantar keratoderma has different age-related characteristics:
- In infants and children, the disease may manifest itself more clearly, which is associated with the activity of the skin and growth characteristics.
- In adults, more pronounced symptoms may be observed, especially with mechanical impact on the skin in everyday life.
- In older people, the risk of complications such as infectious processes is higher due to a general weakening of the immune system.
Questions and Answers
- What are the main symptoms of palmoplantar keratoderma punctata? The main symptoms include the appearance of small, horny growths on the palms of the hands and soles of the feet, which can cause itching and pain.
- What factors may increase the risk of developing TPK 1? Genetic predisposition, physical and chemical factors, and environmental conditions can increase the risk of developing the disease.
- How is TPK 1 diagnosed? Diagnosis includes clinical examination, genetic testing, and skin biopsy if necessary.
- What is the treatment for palmoplantar keratoderma punctata? Treatment may include keratolytic agents, topical corticosteroids, and other methods aimed at improving the skin condition.
- What is the prognosis for this disease? In most cases, the disease can be effectively controlled, but requires regular monitoring to detect complications.
